Supplemental Table 1 from First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0
Joseph Markowitz,Michael Shamblott,Andrew S. Brohl,Amod A. Sarnaik,Zeynep Eroglu,Nikhil I. Khushalani,Christopher W. Dukes,Alejandra Chamizo,Marina Bastawrous, Edward T. Garcia, Ashraf Dehlawi,Pei-Ling Chen,Deanryan B. De Aquino,Vernon K. Sondak,Ahmad A. Tarhini,Youngchul Kim,Patricia Lawman,Shari Pilon-Thomas crossref（2024）
AI 理解论文
溯源树
样例
